We performed transposase-accessible chromatin sequencing (ATAC-seq) analysis of 42 BC samples, including 35 ER-positive(+) human epidermal growth factor receptor 2 (HER2)-negative(−) and 7 triple-negative tumours. This evidence concerns the gene ERBB2 and breast cancer.